ask="9.88"
ask_size="6000"
average_daily_volume="978910"
bid="5.52"
bid_size="5000"
book_value="0.05"
change="-0.26"
change_from_200_day_moving_average="0.36"
change_from_50_day_moving_average="-0.52"
change_from_52_week_high="-1.96"
change_From_52_week_low="3.71"
change_in_percent="-4.44%"
close="5.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="46578000"
high="5.92"
high_52_weeks="7.56"
last_trade_date="2/23/2017"
last_trade_price="5.60"
last_trade_size="38311"
last_trade_time="4:00pm"
low="5.58"
low_52_weeks="1.89"
market_capitalization="413.04M"
moving_average_200_day="5.24"
moving_average_50_day="6.12"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.10"
open="5.88"
pe_ratio="N/A"
peg_ratio="-0.36"
percent_change_from_200_day_moving_average="+6.79%"
percent_change_from_50_day_moving_average="-8.43%"
percent_change_from_52_week_high="-25.93%"
percent_change_from_52_week_low="+196.30%"
previous_close="5.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="108.52"
price_per_sales="19.67"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="1173630"
weeks_range_52="1.89 - 7.56"
